www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHTue, 28 Apr 2026 21:58:51 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netMon, 27 Apr 2026 15:05:01 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-gedeptin-r-as-a-potential-immune-sensitizing-platform-amid-rising-industry-investment-in-in-vivo-cancer-therapies-15637934

EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-gedeptin-r-as-a-potential-immune-sensitizing-platform-amid-rising-industry-investment-in-in-vivo-cancer-therapies-15637934Wed, 15 Apr 2026 22:13:41 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-reports-2025-year-end-financial-results-and-provides-business-update-15613403 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Reports 2025 Year-End Financial Results and Provides Business Update 15.04.2026 / 22:13 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-reports-2025-year-end-financial-results-and-provides-business-update-15613403Tue, 14 Apr 2026 15:05:39 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-positions-geo-mva-to-address-supply-constraints-in-global-mpox-and-smallpox-vaccine-market-15609861 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market 14.04.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-positions-geo-mva-to-address-supply-constraints-in-global-mpox-and-smallpox-vaccine-market-15609861Thu, 02 Apr 2026 15:06:00 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-single-dose-mpox-vaccine-data-at-world-vaccine-congress-2026-15592123 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax Highlights Single-Dose Mpox Vaccine Data at World Vaccine Congress 2026 02.04.2026 / 15:06 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-single-dose-mpox-vaccine-data-at-world-vaccine-congress-2026-15592123Wed, 25 Mar 2026 14:03:12 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-provides-update-on-geo-mva-program-15575983 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Provides Update on GEO-MVA Program 25.03.2026 / 14:03 CET/CEST The issuer is solely responsible ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-provides-update-on-geo-mva-program-15575983Thu, 12 Mar 2026 14:04:01 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-announces-european-society-of-medicine-publication-highlighting-geo-cm04s1-as-a-next-generation-covid-19-vaccine-for-immunocompromised-patients-15551868 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-announces-european-society-of-medicine-publication-highlighting-geo-cm04s1-as-a-next-generation-covid-19-vaccine-for-immunocompromised-patients-15551868Wed, 11 Mar 2026 14:04:02 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-initiates-outreach-regarding-future-procurement-of-geo-mva-mpox-smallpox-vaccine-15549109 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine 11.03.2026 / 14:04 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-initiates-outreach-regarding-future-procurement-of-geo-mva-mpox-smallpox-vaccine-15549109Tue, 24 Feb 2026 15:04:31 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-announces-oncology-advisory-board-to-advance-gedeptin-r-development-across-solid-tumors-15512503 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors 24.02.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-announces-oncology-advisory-board-to-advance-gedeptin-r-development-across-solid-tumors-15512503Wed, 18 Feb 2026 15:04:53 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-secures-exclusive-license-for-gedeptin-r-immune-checkpoint-inhibitor-combination-technology-15500199 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology 18.02.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-secures-exclusive-license-for-gedeptin-r-immune-checkpoint-inhibitor-combination-technology-15500199Tue, 17 Feb 2026 15:04:21 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-endorses-global-call-to-sustain-mpox-response-as-evidence-confirms-epidemic-is-far-from-over-15497513 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Endorses Global Call to Sustain Mpox Response as Evidence Confirms Epidemic Is Far From Over 17.02.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-endorses-global-call-to-sustain-mpox-response-as-evidence-confirms-epidemic-is-far-from-over-15497513